VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,361,367 | +2.1% | 1,164,405 | 0.0% | 3.94% | +13.5% |
| Q2 2023 | $58,150,386 | +11.0% | 1,164,405 | -16.7% | 3.47% | -8.4% |
| Q1 2023 | $52,374,739 | -21.8% | 1,397,405 | 0.0% | 3.79% | -9.0% |
| Q4 2022 | $67,005,570 | +80.4% | 1,397,405 | -9.7% | 4.17% | +45.7% |
| Q3 2022 | $37,138,000 | -4.5% | 1,547,405 | -13.4% | 2.86% | -22.1% |
| Q2 2022 | $38,894,000 | -30.3% | 1,787,405 | -22.6% | 3.67% | -22.8% |
| Q1 2022 | $55,776,000 | – | 2,309,554 | – | 4.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
| Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
| Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
| RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
| COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
| GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
| ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
| Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
| Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
| BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |